Effects of 5‑Aza‑2'‑deoxycytidine on the methylation state and function of the WWOX gene in the HO‑8910 ovarian cancer cell line

Yan,Hongchao; Yu,Nan; Tong,Jianye

doi:10.3892/ol.2013.1438

September 2013 Volume 6 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

September 2013 Volume 6 Issue 3

Full Size Image

Article

Effects of 5‑Aza‑2'‑deoxycytidine on the methylation state and function of the WWOX gene in the HO‑8910 ovarian cancer cell line

Authors:
- Hongchao Yan
- Nan Yu
- Jianye Tong
View Affiliations / Copyright

Affiliations: Department of Obstetrics and Gynecology, The Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu 221002, P.R. China
Pages: 845-849
|
Published online on: July 3, 2013

https://doi.org/10.3892/ol.2013.1438
Expand metrics +

Abstract

The aim of this study was to explore the effects of 5‑Aza‑2'‑deoxycytidine (5‑Aza‑CdR), a DNA methylation inhibitor, on the methylation state and function of the WWOX gene in the HO‑8910 ovarian cancer cell line. The HO‑8910 cells were divided into two groups, a control group and a 5‑Aza‑CdR‑treated group. The methylation state of the WWOX gene was evaluated using a methylation‑specific PCR assay. The effect of 5‑Aza‑CdR on the HO‑8910 cells was analyzed using MTT and cell invasion assays, as well as flow cytometry. The animal models were established by intraperitoneal transplantation of the cells into nude mice. Following treatment with 5‑Aza‑CdR, a demethylation state was detected in the HO‑8910 cells. WWOX protein expression was significantly higher in the 5‑Aza‑CdR‑treated group compared with that in the control group. The cell growth rate at each tested time point and the number of invasive cells were lower in the 5‑Aza‑CdR‑treated group compared with that in the control group. Flow cytometry revealed that 67.13% of the cells were arrested at the G0/G1 stage in the 5‑Aza‑CdR‑treated group. The tumorigenic ability of the 5‑Aza‑CdR‑treated group was lower compared with that of the control group. In conclusion, the methylation state of the WWOX gene in HO‑8910 cells may be reversed using 5‑Aza‑CdR, which may also inhibit the growth of these cells.

View Figures

View References

1	Barton CA, Hacker NF, Clark SJ and O’Brien PM: DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment. Gynecol Oncol. 109:129–139. 2008. View Article : Google Scholar : PubMed/NCBI
2	Houshdaran S, Hawley S, Palmer C, et al: DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines. PLoS One. 5:e93592010. View Article : Google Scholar : PubMed/NCBI
3	Bednarek AK, Laflin KJ, Daniel RL, et al: WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3–24.1, a region frequently affected in breast cancer. Cancer Res. 60:2140–2145. 2000.PubMed/NCBI
4	Del Mare S, Salah Z and Aqeilan RI: WWOX: its genomics, partners, and functions. J Cell Biochem. 108:737–745. 2009.PubMed/NCBI
5	Lewandowska U, Zelazowski M, Seta K, et al: WWOX, the tumour suppressor gene affected in multiple cancers. J Physiol Pharmacol. 60:47–56. 2009.PubMed/NCBI
6	Wang X, Chao L, Jin G, et al: Association between CpG island methylation of the WWOX gene and its expression in breast cancers. Tumour Biol. 30:8–14. 2009. View Article : Google Scholar : PubMed/NCBI
7	Dehan P, Kustermans G, Guenin S, et al: DNA methylation and cancer diagnosis: new methods and applications. Expert Rev Mol Diagn. 9:651–657. 2009. View Article : Google Scholar : PubMed/NCBI
8	Worthley DL, Whitehall VL, Buttenshaw RL, et al: DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. Oncogene. 29:1653–1662. 2010. View Article : Google Scholar : PubMed/NCBI
9	Kiran M, Chawla YK and Kaur J: Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India. Cancer Genet Cytogenet. 195:112–119. 2009. View Article : Google Scholar : PubMed/NCBI
10	Sharma G, Mirza S, Parshad R, et al: CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients. Clin Biochem. 43:373–379. 2010. View Article : Google Scholar : PubMed/NCBI
11	Kuroda A, Rauch TA, Todorov I, et al: Insulin gene expression is regulated by DNA methylation. PLoS One. 4:e69532009. View Article : Google Scholar : PubMed/NCBI
12	Lewandowska J and Bartoszek A: DNA methylation in cancer development, diagnosis and therapy - multiple opportunities for genotoxic agents to act as methylome disruptors or remediators. Mutagenesis. 26:475–487. 2011. View Article : Google Scholar : PubMed/NCBI
13	Gaudet MM, Campan M, Figueroa JD, et al: DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations. Cancer Epidemiol Biomarkers Prev. 18:3036–3043. 2009. View Article : Google Scholar : PubMed/NCBI
14	Weng YI, Huang TH and Yan PS: Methylated DNA immunoprecipitation and microarray-based analysis: detection of DNA methylation in breast cancer cell lines. Methods Mol Biol. 590:165–176. 2009. View Article : Google Scholar : PubMed/NCBI
15	Sceusi EL, Loose DS and Wray CJ: Clinical implications of DNA methylation in hepatocellular carcinoma. HPB (Oxford). 13:369–376. 2011. View Article : Google Scholar : PubMed/NCBI
16	Espada J and Esteller M: DNA methylation and the functional organization of the nuclear compartment. Semin Cell Dev Biol. 21:238–246. 2010. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Effects of 5‑Aza‑2'‑deoxycytidine on the methylation state and function of the WWOX gene in the HO‑8910 ovarian cancer cell line

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Related Articles